4
HAFEDH ET AL.
127.3 (CH); 127.3 (CH); 127.4 (2CH); 127.7 (CH); 127.9
(CH); 127.9 (CH); 128.5 (2CH); 128.5 (C); 128.9 (C);
129.1 (C); 129.2 (C); 130.6 (C); 131.4 (C); 131.9 (C);
131.9 (C); 133.6 (C); 145.9 (C3). HRMS (MALDI‐TOF)
[M+] (C33H29N2+): calc. 353.2325; found 353.2320.
7.65‐7.78 (m, 2H); 7.80‐7.86 (m, 3H); 8.06 (dd, J1 = 1.2
Hz, J2 = 8 Hz, 1H, H13); 8.97 (s, 1H, H1); 9.08 (d, J =
8.4 Hz, 1H, H13). HRMS (ESI MS) [M+Na]+ (C33H36N2
35-
ClNa193Rh): calcd. 607.1489; found 607.14845.
2.1.7 | Iridium complex of [6]helicene‐
NHC 1b
2.1.5 | Iridium complex of [4]helicene‐
NHC 1a
In a Schlenk tube under argon, were placed successively
[Ir(COD)Cl]2 (48.4 mg, 0.07 mmol, 0.6 eq.), t‐BuOK
(13.5 mg, 0.12 mmol, 1 eq.), and dry THF (5 mL). After
stirring for 10 minutes at room temperature, imidazolium
salt 4b (58.5 mg, 1 eq.) was added, and the solution was
stirred at room temperature for 13 hours. The solvent
was stripped off, and the crude mixture was purified by
flash chromatography over silica gel (diethyl ether as
the eluent) to give complex 1b (62 mg, 65%) as a yellow
In a Schlenk tube under argon, were placed successively
[Ir(COD)Cl]2 (48.4 mg, 0.07 mmol, 0.6 eq.), t‐BuOK
(13.5 mg, 0.12 mmol, 1 eq.), and dry THF (5 mL). After
stirring for 10 minutes at room temperature, imidazolium
salt 4a (50 mg) was added, and the solution was stirred at
room temperature for 13 hours. The solvent was stripped
off, and the crude mixture was purified by flash chroma-
tography over silica gel (diethyl ether as the eluent) to
give complex 1a (63 mg, 76%) as a yellow solid. Mp =
solid. Mp = 269°C. HRMS (ESI) [M+Na]+ (C41H40N2
35-
1
ClNa193Ir): calcd. 811.24016; found 811.2404(0).
252‐254°C. H NMR (400 MHz, CDCl3): δ 1.20‐1.25 (m,
6H, Hc,c′); 1.73‐1.80 (m, 2H, COD); 1.86‐1.95 (m, 2H,
COD); 2.04‐2.17 (m, 2H, 2Hb); 2.28‐2.39 (m, 6H, 4H from
COD and 2Hb,b′); 3.08 (s, 2H, COD); 4.73‐4.93 (m, 6H, 2H
from COD and 4Ha,a′); 7.65‐7.74 (m, 2H); 7,79 (d, J = 8.4
Hz, 1H); 7.84‐7.86 (m, 2H); 7.92‐7.96 (m, 2H); 8.07 (dd, J1
= 1.6 Hz, J2 = 8 Hz, 1H); 8.98 (s, 1H, H1); 9.08 (d, J = 8.4
Hz, 1H, H13). 13C NMR (101 MHz, CDCl3): δ 11.9 (CH3);
11.95 (CH3); 23.0 (CH2), 23.2 (CH2), 29.4 (CH2); 29.5
(CH2); 33.6 (CH2); 33.7 (CH2); 50.3 (CH2); 50.4 (CH2);
52.7 (CH); 52.7 (CH); 87.2 (CH); 87.3 (CH); 107.0 (CH);
107.7 (CH); 125.9 (C); 126.0 (CH); 126.25 (CH); 126.3
(CH); 126.85 (2CH); 127.2 (C); 127.3 (CH); 127.4 (CH);
128.8 (CH); 129.6 (C); 130.2 (C); 130.45 (C); 133.5 (C);
134.0 (C); 134.70 (C); 197.0 (C3). HRMS (ESI MS) [M
+Na]+ (C33H36N235ClNa193Ir): calcd. 711.2089; found
711.2079.
The mixture of four diastereomers was then separated
by HPLC over a chiral stationnary phase (Chiralpak IG,
eluent: hexane/ethanol/dichloromethane (80/10/10), see
Supporting Information) to yield complexes 1b1 and 1b2.
23
First eluted: (P)‐1b1 > 99% ee, ½αꢀD = +2750; second
23
eluted: (M)‐1b1 > 98% ee, ½αꢀD = −2121; third eluted:
23
(P)‐1b2 > 98% ee, ½αꢀD = +2703; fourth eluted: (M)‐1b2
23
> 98% ee, ½αꢀD = −1860 (CH2Cl2, 5 × 10−5 M). Some
isomerization process between 1b1 and 1b2 stereoisomers
was observed (see below and in Supporting Information).
2.2 | Complex 1b1
1H NMR (500 MHz, CD2Cl2): δ 0.73 (t, J = 7.5 Hz, 3H,
H20); 1,09 (t, J = 7.5 Hz, 3H, H23); 1.12‐1.26 (m, 2H);
1.69‐1.77 (m, 2H, H19); 1.79‐1.86 (m, 2H); 1.88‐1.96 (m,
1H, H22); 2.07‐2.15 (m, 1H, H22); 2.17‐2.32 (m, 4H); 2,80
(td, J1 = 2.5 Hz, J2 = 7 Hz, 1H, H2′); 2.96‐2.98 (m, 1H,
H1′); 3.69‐3.75 (m, 1H, H18); 4.05‐4.10 (m, 1H, H18);
4.52‐4.58 (m, 2H, H21, and H5′/6′); 4.59‐4.63 (m, 1H, H5′/
6′); 4.68‐4.74 (m, 1H, H21); 6.50‐6.53 (m, 1H, H16); 7.10
(td, J1 = 1 Hz, J2 = 8 Hz, 1H, H15); 7.46 (s, 1H, H1);
7.48 (d, J = 8.5 Hz, 1H, H17); 7.70 (s, 1H, H5); 7.84 (d, J
= 7.5 Hz, 1H, H14); 7.94 (d, J = 8.5 Hz, 1H); 7.98 (d, J =
8.5 Hz, 1H); 8.01‐8.09 (m, 6H). 13C NMR (126 MHz,
CD2Cl2): δ 11.65 (C20); 12.0 (C23); 22.8 (C19), 23.4 (C22),
29.8 (CH2); 30.0 (CH2); 33.9 (CH2); 34.1 (CH2); 50.15
(C18); 50.55 (C21); 53.,0 (C1′/2′); 53.05 (C1′/2′); 86.9 (C5′/
6′); 87.0 (C5′/6′); 106.8 (C5); 108.3 (C1); 124.3; 125.1;
126.1; 126.2; 126.2; 127.25; 127.3; 127.7; 127.8; 127.8;
127.8; 127.9; 127.9; 128.1; 128.3; 128.4; 128.7; 130.0;
131.5; 132.1; 132.45; 133.8; 134.1; 133.7; 196.6 (C3).
2.1.6 | Rhodium complex of [4]helicene‐
NHC 1′a
In a Schlenk tube under argon, were placed successively
[Rh(COD)Cl]2 (38.9 mg, 0.08 mmol, 0.6 eq.), t‐BuOK
(14.75 mg, 0.13 mmol, 1eq.), and dry THF(5 mL). After
stirring for 10 minutes at room temperature, imidazolium
salt 3a (51 mg) was added, and the solution was stirred at
room temperature for 13 hours. The solvent was stripped
off, and the crude mixture was purified by flash chroma-
tography over silica gel (diethyl ether as the eluent) to
give complex 1′a (40 mg, 51%) as a yellow solid. Mp =
1
240‐243°C. H NMR (400 MHz, CDCl3): δ1.25‐1.30 (m,
6H, Hc,c′); 2.07‐2.19 (m, 6H, 2H from COD and 2Hb);
2.37‐2.57 (m, 6H, 2H from COD and 2Hb′); 3.48 (s, 2H,
COD); 4.88‐5.06 (m, 4H, Ha,a′); 4.73‐5.25 (s, 2H, COD);